These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8456649)

  • 1. Merrill C. Sosman Lecture. The Auger process: a therapeutic promise?
    Adelstein SJ
    AJR Am J Roentgenol; 1993 Apr; 160(4):707-13. PubMed ID: 8456649
    [No Abstract]   [Full Text] [Related]  

  • 2. Therapeutic applications of Auger and alpha emitting radionuclides.
    Bloomer WD; McLaughlin WH; Adelstein SJ; Wolf AP
    Strahlentherapie; 1984 Dec; 160(12):755-7. PubMed ID: 6393458
    [No Abstract]   [Full Text] [Related]  

  • 3. 5-125I-iododeoxyuridine as prototype for radionuclide therapy with Auger emitters.
    Bloomer WD; Adelstein SJ
    Nature; 1977 Feb; 265(5595):620-1. PubMed ID: 859560
    [No Abstract]   [Full Text] [Related]  

  • 4. Preclinical animal studies with radioiododeoxyuridine.
    Kassis AI; Adelstein SJ
    J Nucl Med; 1996 Apr; 37(4 Suppl):10S-12S. PubMed ID: 8676195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic application of iodine-125 labeled iododeoxyuridine in an early ascites tumour model.
    Bloomer WD; Adelstein SJ
    Curr Top Radiat Res Q; 1978 Jan; 12(1-4):513-25. PubMed ID: 639561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bystander effect produced by radiolabeled tumor cells in vivo.
    Xue LY; Butler NJ; Makrigiorgos GM; Adelstein SJ; Kassis AI
    Proc Natl Acad Sci U S A; 2002 Oct; 99(21):13765-70. PubMed ID: 12368480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-(125I)-iododeoxyuridine and the Auger effect: biological consequences and implications for therapy.
    Bloomer WD; Adelstein SJ
    Pathobiol Annu; 1978; 8():407-21. PubMed ID: 364377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement of the intensity ratio of Auger and conversion electrons for the electron capture decay of
    Alotiby M; Greguric I; Kibédi T; Lee BQ; Roberts M; Stuchbery AE; Tee P; Tornyi T; Vos M
    Phys Med Biol; 2018 Mar; 63(6):06NT04. PubMed ID: 29480815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microdosimetric basis of individualized cancer radiotherapy by radionuclides including Auger effect and the photon activation approach.
    Booz J
    Strahlentherapie; 1984 Dec; 160(12):745-54. PubMed ID: 6393457
    [No Abstract]   [Full Text] [Related]  

  • 10. On the equivalent dose for Auger electron emitters.
    Howell RW; Narra VR; Sastry KS; Rao DV
    Radiat Res; 1993 Apr; 134(1):71-8. PubMed ID: 8475256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Letter: Antineoplastic effect of iodine-125-labelled iododeoxyuridine.
    Bloomer WD; Adelstein SJ
    Int J Radiat Biol Relat Stud Phys Chem Med; 1975 May; 27(5):509-11. PubMed ID: 1080145
    [No Abstract]   [Full Text] [Related]  

  • 12. [Experimental radiotherapy, a research plan from radiobiology].
    Hagen U
    Strahlenschutz Forsch Prax; 1985; 26():28-30. PubMed ID: 4089905
    [No Abstract]   [Full Text] [Related]  

  • 13. Strategies for selective targeting of Auger electron emitters to tumor cells.
    O'Donoghue JA
    J Nucl Med; 1996 Apr; 37(4 Suppl):3S-6S. PubMed ID: 8676202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 125I interstitial implants in the RIF-1 murine flank tumor: an animal model for brachytherapy.
    Bernstein M; Gutin PH; Weaver KA; Deen DF; Barcellos MH
    Radiat Res; 1982 Sep; 91(3):624-37. PubMed ID: 6750681
    [No Abstract]   [Full Text] [Related]  

  • 15. Molecular consequences of the Auger effect: the fate of iododeoxyuridine following iodine-125 decay.
    Keough G; Hofer KG
    Radiat Res; 1976 Aug; 67(2):224-34. PubMed ID: 948550
    [No Abstract]   [Full Text] [Related]  

  • 16. Radiation quality-dependent bystander effects elicited by targeted radionuclides.
    Boyd M; Sorensen A; McCluskey AG; Mairs RJ
    J Pharm Pharmacol; 2008 Aug; 60(8):951-8. PubMed ID: 18644188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Photon activation of iododeoxyuridine: biological efficacy of Auger electrons.
    Laster BH; Thomlinson WC; Fairchild RG
    Radiat Res; 1993 Feb; 133(2):219-24. PubMed ID: 8438063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen receptor-directed radiotoxicity with Auger electrons: specificity and mean lethal dose.
    DeSombre ER; Shafii B; Hanson RN; Kuivanen PC; Hughes A
    Cancer Res; 1992 Oct; 52(20):5752-8. PubMed ID: 1394199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Auger cascade and therapeutic applications of 125I.
    Feige Y
    Curr Top Radiat Res Q; 1978 Jan; 12(1-4):3-11. PubMed ID: 639553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential for tumor therapy with iodine-125 labeled immunoglobulins.
    Adelstein SJ; Kassis AI; Baranowska-Kortylewicz J; van den Abbeele AD; Mariani G; Ito S
    Int J Rad Appl Instrum B; 1991; 18(1):43-4. PubMed ID: 2010304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.